Partner with us

No needles. No cuffs. Just health tracking that blends into daily life

World’s first non-invasive device and platform that
measures key health markers, including blood glucose
and blood pressure.

LifeLeaf continuously monitors multiple chronic care biomarkers and
provides AI-driven real-time insights to proactively manage your health,
without getting in the way.
What is LifeLeaf
LifeLeaf near me
Clinical evidence
hugging1

Measure multiple biomarkers continuously with a
single, non-invasive device

Track your trends in real-time from the app or right from your wrist.

Blood Glucose

Measure multiple biomarkers continuously with a
single, non-invasive device

Track your trends in real-time from the app or right from your wrist.

Blood Glucose

Blood Pressure

Steps

Oxygen Saturation

Less barriers and improved adherence for a healthier population

Remote monitoring devices can feel awkward and difficult to incorporate into everyday life, making patient adherence challenging. 

Without consistent use, it’s hard to find trends and fight chronic diseases.  LifeLeaf is a clinically proven, globally accessible and low-cost medical device with the look and feel of an elegant smartwatch.

LifeLeaf easily tracks patients’ health with the comfort of a lightweight and discreet device. It’s comfortable enough to wear around the clock, making patient adherence easy. With simple and painless adherence comes continuous data, observable trends, and ultimately, healthier populations.

What it measures
czarny2_new-1
Glucose readings are within 10% MARD* against BGM reference.
Systolic BP readings are
within –0.02 ± 12.5 mmHg and diastolic BP readings are within 0.03± 8.4 mmHg against BP cuff.
(*Mean Absolute Relative Difference)
Glucose readings are within 10% MARD* against BGM reference.
Systolic BP readings are within –0.02 ± 12.5 mmHg and diastolic BP readings are within 0.03± 8.4 mmHg against BP cuff.
(*Mean Absolute Relative Difference)

A better way to
manage chronic care

Fully integrated remote patient 
monitoring platform

Connects the dots so patients don’t have to

While other home-use medical devices measure data in discrete points, LifeLeaf gathers continuous, high-volume medical-grade data, right from the wrist, making it easy to detect trends. 

Brings health data together in one place

From fitness to nutrition and overall lifestyle, the LifeLeaf platform easily connects with 3rd party data sources to deliver a bigger picture.

plusicon

THE APP
Provides simple visuals explaining trends, actionable insights, and the ability to share health records.

plusicon

THE CLOUD
Patient health trends, accessible from anywhere.

plusicon

USER PORTAL
Patients can view long-term trends and detailed health records.

plusicon

THE DEVICE
Single non-invasive, effortless wrist-worn device that monitors multiple key biomarkers.

plusicon

CAREGIVER PORTAL
Allows care teams to view real-time health trends and engage in proactive care management.

THE APP

LifeLeaf provides simple visuals explaining trends, actionable insights and alerts, and the ability to share health records from anywhere.

THE DEVICE

Single non-invasive, effortless wrist-worn device that monitors multiple key biomarkers.

USER PORTAL

Patients can view long-term trends and detailed health records from anywhere.

CAREGIVER PORTAL

Allows care teams to view real-time health trends and engage in proactive care management from anywhere.

Built on a strong foundation of
clinical evidence

LifePlus has completed multiple clinical feasibility studies in the US and across the world with over 70,000 paired data points from 500+ subjects in both clinical and real-world settings.

LifeLeaf’s impressive performance and extraordinary method of measuring biomarkers has also been highlighted in the world’s leading clinical meetings.

As LifeLeaf continues to provide people with better health tracking, additional global multi-site studies are enrolling to demonstrate the improved outcomes LifeLeaf delivers.

LifePlus has completed multiple clinical feasibility studies in the US and across the world with over 70,000 paired data points from 500+ subjects in both clinical and real-world settings. LifeLeaf’s impressive performance and extraordinary method of measuring biomarkers has also been highlighted in the world’s leading clinical meetings. As LifeLeaf continues to provide people with better health tracking, additional global multi-site studies are enrolling to demonstrate the improved outcomes LifeLeaf delivers.
The feasibility of non-invasive continuous glucose monitoring with the novel LifeLeaf wristwatch and platform T. BAILEY, J. FISCHER, M. KOHN, I. SEN-GUPTA, J. BROZ, A. SANYAL, B. MBOUOMBOUO, N. BANERJEE DIABETES TECHNOLOGY & THERAPEUTICS, VOL. 25, SUPP. 2, 2023, PP. A-250 IRB-controlled multi-site feasibility study demonstrated clinical grade performance of LifeLeaf blood glucose readings against BGM and CGM reference. Read the article
The feasibility of cuffless, non-occlusive blood pressure assessments using the novel LifeLeaf wristwatch and platform W. ALMAHMEED, D. KUMAR, B. MBOUOMBOUO, N. BANERJEE, A. SANYAL, I. SEN-GUPTA JOURNAL OF HYPERTENSION, VOL. 41, SUPP. 3, 2023, PP. E111-112 IRB-controlled multi-site feasibility study demonstrated clinical grade performance of LifeLeaf blood pressure readings against cuff reference. Read the article

LifePlus has completed multiple clinical feasibility studies in the US and across the world with over 70,000 paired data points from 500+ subjects in both clinical and real-world settings.

LifeLeaf’s impressive performance and extraordinary method of measuring biomarkers has also been highlighted in the world’s leading clinical meetings.

As LifeLeaf continues to provide people with better health tracking, additional global multi-site studies are enrolling to demonstrate the improved outcomes LifeLeaf delivers.

Slide 1

Improved accuracy of a fully non-invasive CGM on a diverse population

T. BAILEY, J. FISCHER, I. SEN-GUPTA, B. MBOUOMBOUO, A. SANYAL

DIABETES, VOL. 74, SUPP. 1, 2025

Using real-world data, demonstrated feasibility of a truly non-invasive CGM on a diverse population from 248 end users from 12 countries.


Download PDF
Slide 2

The feasibility of non-invasive continuous glucose monitoring with the novel LifeLeaf wristwatch and platform

T. BAILEY, J. FISCHER, M. KOHN, I. SEN-GUPTA, J. BROZ, A. SANYAL, B. MBOUOMBOUO, N. BANERJEE

DIABETES TECHNOLOGY & THERAPEUTICS, VOL. 25, SUPP. 2, 2023, PP. A-250

IRB-controlled multi-site feasibility study demonstrated clinical grade performance of LifeLeaf blood glucose readings against BGM and CGM reference.


Download PDF
Slide 2

The feasibility of cuffless, non-occlusive blood pressure assessments using the novel LifeLeaf wristwatch and platform

W. ALMAHMEED, D. KUMAR, B. MBOUOMBOUO, N. BANERJEE, A. SANYAL, I. SEN-GUPTA

JOURNAL OF HYPERTENSION, VOL. 41, SUPP. 3, 2023, PP. E111-112

IRB-controlled multi-site feasibility study demonstrated clinical grade performance of LifeLeaf blood pressure readings against cuff reference.


Download PDF
Slide 3

Paradigm shift in chronic care management

No ongoing consumables, reduced long-term costs

With LifeLeaf, there’s no need to manage an ongoing supply chain of finger sticks, needles or sensors. It’s a single piece of hardware. That’s it. 

Improved access to chronic care reimbursement

Delivers a seamless capture, retention and presentation of health data to ensure maximum reimbursement.

Built for stretched care teams

Less time spent managing adherence means more time for more patients. LifeLeaf allows care teams to be more efficient and effective.